Cargando…

The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region

The World Health Organization (WHO) recommends that countries introduce rubella containing vaccines (RCVs) to reduce rubella circulation and the occurrence of congenital rubella syndrome (CRS). As of June 2017, a total of 18 countries have already introduced or are in the process of introducing RCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Luce, Richard, Masresha, Balcha G, Katsande, Regis, Fall, Amadou, Shibeshi, Messeret Eshetu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446993/
https://www.ncbi.nlm.nih.gov/pubmed/30957104
_version_ 1783408451695673344
author Luce, Richard
Masresha, Balcha G
Katsande, Regis
Fall, Amadou
Shibeshi, Messeret Eshetu
author_facet Luce, Richard
Masresha, Balcha G
Katsande, Regis
Fall, Amadou
Shibeshi, Messeret Eshetu
author_sort Luce, Richard
collection PubMed
description The World Health Organization (WHO) recommends that countries introduce rubella containing vaccines (RCVs) to reduce rubella circulation and the occurrence of congenital rubella syndrome (CRS). As of June 2017, a total of 18 countries have already introduced or are in the process of introducing RCV in routine child vaccination programs. RCV introduction during 2013 - 2014 in five countries in the Region resulted in a reduction of rubella incidence of 48% to 96% in the post-introduction period as compared to the average incidence in the years before introduction. These results suggest that initial mass vaccination campaigns and introduction of RCVs in routine immunization programs result in significant reduction in rubella incidence and a reduced potential for the occurrence of CRS.
format Online
Article
Text
id pubmed-6446993
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-64469932019-04-03 The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region Luce, Richard Masresha, Balcha G Katsande, Regis Fall, Amadou Shibeshi, Messeret Eshetu J Immunol Sci Article The World Health Organization (WHO) recommends that countries introduce rubella containing vaccines (RCVs) to reduce rubella circulation and the occurrence of congenital rubella syndrome (CRS). As of June 2017, a total of 18 countries have already introduced or are in the process of introducing RCV in routine child vaccination programs. RCV introduction during 2013 - 2014 in five countries in the Region resulted in a reduction of rubella incidence of 48% to 96% in the post-introduction period as compared to the average incidence in the years before introduction. These results suggest that initial mass vaccination campaigns and introduction of RCVs in routine immunization programs result in significant reduction in rubella incidence and a reduced potential for the occurrence of CRS. 2018-07-28 /pmc/articles/PMC6446993/ /pubmed/30957104 Text en http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Luce, Richard
Masresha, Balcha G
Katsande, Regis
Fall, Amadou
Shibeshi, Messeret Eshetu
The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region
title The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region
title_full The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region
title_fullStr The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region
title_full_unstemmed The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region
title_short The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region
title_sort impact of recent rubella vaccine introduction in 5 countries in the african region
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446993/
https://www.ncbi.nlm.nih.gov/pubmed/30957104
work_keys_str_mv AT lucerichard theimpactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT masreshabalchag theimpactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT katsanderegis theimpactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT fallamadou theimpactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT shibeshimessereteshetu theimpactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT lucerichard impactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT masreshabalchag impactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT katsanderegis impactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT fallamadou impactofrecentrubellavaccineintroductionin5countriesintheafricanregion
AT shibeshimessereteshetu impactofrecentrubellavaccineintroductionin5countriesintheafricanregion